An overview on the delivery of antitumor drug doxorubicin by carrier proteins

作者：Agudelo D; Berube G; Tajmir Riahi H A

来源：International Journal of Biological Macromolecules, 2016, 88: 354-360.

DOI：10.1016/j.ijbiomac.2016.03.060

• Doxorubicin
• Protein
• Drug delivery
• Hydrophobicity
• Modeling
• Spectroscopy

Serum proteins play an increasing role as drug carriers in the clinical settings. In this review, we have compared the binding modalities of anticancer drug doxorubicin (DOX) to three model carrier proteins, human serum albumin (HSA), bovine serum albumin (BSA) and milk beta-lactoglobulin (beta-LG) in order to determine the potential application of these model proteins in DOX delivery. Molecular modeling studies showed stronger binding of DOX with HSA than BSA and beta-LG with the free binding energies of -10.75 (DOX-HSA), -9.31 (DOX-BSA) and -8.12 kcal/mol (DOX-beta-LG). Extensive H-boding network stabilizes DOX-protein conjugation and played a major role in drug-protein complex formation. DOX complexation induced major alterations of HSA and BSA conformations, while did not alter beta-LG secondary structure. The literature review shows that these proteins can potentially be used for delivery of DOX in vitro and in vivo.

• 出版日期2016-7